ScreenIn3D Limited

Hooke Bio

This company develops a microfluidic platform using three-dimensional human tissue models for preclinical drug testing for pharmaceutical and biotechnology organisations.

Organo-ID

The company develops 3D organoid models and drug response tests for cancer patients and pharmaceutical researchers to improve personalised medicine and treatment efficacy.

Known Medicine

This company develops a platform using 3D cell culture and artificial intelligence to predict drug responses for oncologists and biopharmaceutical developers.

Kiyatec

This company develops 3D cell culture platforms to predict patient-specific responses to cancer therapies for oncologists and biopharmaceutical companies.

Finnadvance

This company develops microfluidic organ-on-chip platforms for pharmaceutical and academic researchers to perform drug testing and mimic human organ functions.

Carcinotech

Carcinotech manufactures 3D-bioprinted, patient-derived tumour models for drug developers and oncologists to perform rapid and ethical cancer drug testing and personalised medicine.

Fluid Screen

This company develops lab-on-a-chip systems to detect and identify bacterial contamination in fluids for biotherapeutics manufacturers, healthcare providers and water quality monitoring services.

Verinnogen

This company develops handheld 3D surface-profiling devices for measuring subcutaneous tumours to support pre-clinical oncology researchers and drug developers.